AIMD: Ainos, Inc. Stock

by  •  • Comments Off on AIMD: Ainos, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.69
Enterprise Value ($M) 13.80
Book Value ($M) 15.52
Book Value / Share 1.28
Price / Book 0.37
NCAV ($M) -8.97
NCAV / Share -0.64
Price / NCAV -0.75

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.66

Liquidity (mrq)
Quick Ratio 1.06
Current Ratio 1.37

Balance Sheet (mrq) ($M)
Current Assets 4.34
Assets 28.82
Liabilities 13.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -13.84
Net Income -14.86
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -5.81
Cash from Investing -0.13
Cash from Financing 8.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-27 13D/A Ainos Inc 16.89 0.00
08-21 13D Taiwan Carbon Nano Technology Corp 40.23
05-08 13D Advanced Semiconductor Engineering Inc 27.40
05-06 13D/A Amarillo Biosciences Inc 63.36 76.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 46,916 117,168 40.04
2025-03-06 9,076 89,155 10.18
2025-03-05 514,774 1,205,865 42.69
2025-03-04 70,214 131,848 53.25

(click for more detail)

Similar Companies
ADTX – Aditxt, Inc. ADVM – Adverum Biotechnologies, Inc.
AGEN – Agenus Inc. AKAN – Akanda Corp.
AKBA – Akebia Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io